Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapyHannah Lust, Rawan Faramand, Liora M. Schultz et al.|Blood Advances|2025Cited by 15
HESTER: A Phase II Study Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia Experiencing Loss of B-Cell AplasiaMichael W. Boyer, Jennifer Willert, Sonali Chaudhury et al.|Blood|2020Cited by 8
S255: EFFICACY AND SAFETY OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) MATURE B-CELL NON-HODGKIN LYMPHOMA (NHL): THE PHASE II BIANCA STUDYVéronique Minard‐Colin, Birgit Burkhardt, Jochen Buechner et al.|HemaSphere|2022Cited by 5
Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell TransplantNicole Liberio, Larisa Broglie, Mariam Allbee-Johnson et al.|Journal of Clinical Oncology|2026Cited by 2
ALL-026: Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion Following Loss of B-Cell Aplasia in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia: HESTER Phase II StudyMichael W. Boyer, Jennifer Willert, Sonali Chaudhury et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 1